tiprankstipranks
PTC Therapeutics (PTCT)
NASDAQ:PTCT
US Market

PTC Therapeutics (PTCT) Income Statement

Compare
352 Followers

PTC Therapeutics Income Statement

Last quarter (Q4 2024), PTC Therapeutics's total revenue was $213.17M, a decrease of -30.58% from the same quarter last year. In Q4, PTC Therapeutics's net income was $-65.89M. See PTC Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 806.78M$ 937.82M$ 698.80M$ 538.59M$ 380.77M
Gross Profit
$ 806.78M$ 872.34M$ 654.12M$ 506.26M$ 361.82M
Operating Expenses
$ 1.11B$ 1.31B$ 1.09B$ 881.21M$ 759.70M
Depreciation and Amortization
$ 75.66M$ 236.59M$ 128.84M$ 71.52M$ 49.58M
EBITDA
$ -120.46M$ -330.34M$ -367.78M$ -374.44M$ -297.00M
Operating Income
$ -302.57M$ -349.40M$ -439.93M$ -374.94M$ -397.88M
Other Income/Expenses
$ -60.55M$ -346.71M$ -147.56M$ -143.40M$ -59.36M
Pretax Income
$ -363.12M$ -696.11M$ -587.49M$ -518.34M$ -402.93M
Net Income
$ -363.30M$ -626.60M$ -559.02M$ -523.90M$ -438.16M
Per Share Metrics
Basic EPS
$ -4.73$ -8.37$ -7.79$ -7.43$ -6.64
Diluted EPS
$ -4.73$ -8.37$ -7.79$ -7.43$ -6.64
Weighted Average Shares Outstanding
76.85M 74.84M 71.73M 70.47M 66.03M
Weighted Average Shares Outstanding (Diluted)
76.85M 74.84M 71.73M 70.47M 66.03M
Currency in USD

PTC Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis